Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases

Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases

Neuromuscular diseases (NMDs) belong to a class of functional impairments that cause dysfunctions of the motor neuron-muscle functional axis components. Inherited monogenic neuromuscular disorders encompass both muscular dystrophies and motor neuron diseases. Understanding of their causative genetic...

Full description

Bibliographic Details
Main Authors:	Wei Chiu, Ya-Hsin Hsun, Kao-Jung Chang, Aliaksandr A. Yarmishyn, Yu-Jer Hsiao, Yueh Chien, Chian-Shiu Chien, Chun Ma, Yi-Ping Yang, Ping-Hsing Tsai, Shih-Hwa Chiou, Ting-Yi Lin, Hao-Min Cheng
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	International Journal of Molecular Sciences
Subjects:	gene therapy CRISPR neuromuscular disease duchenne muscular dystrophy spinal muscular atrophy
Online Access:	https://www.mdpi.com/1422-0067/21/24/9589

Similar Items

De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany
by: Kirsten König, et al.
Published: (2019-06-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
by: Ana Valéria de Araujo Leitão, et al.

Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease
by: Rachel A. Kennedy, et al.
Published: (2020-03-01)

First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases
by: Laurent Servais, et al.
Published: (2021-08-01)

Higher Prevalence of Nonsense Pathogenic <i>DMD</i> Variants in a Single-Center Cohort from Brazil: A Genetic Profile Study That May Guide the Choice of Disease-Modifying Treatments
by: Vitor Lucas Lopes Braga, et al.
Published: (2023-10-01)

Pain characterization in Duchenne muscular dystrophy
by: Talita Dias da Silva, et al.

Study on skeletal muscle dystrophin and neuromuscular junction in adult and young mdx mice
by: Yu-ling ZHU, et al.
Published: (2015-05-01)

Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders
by: Hideyuki Iwayama, et al.
Published: (2022-09-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

A comprehensive database of Duchenne and Becker muscular dystrophy patients in Children's Hospital of Fudan University
by: Xi-hua LI, et al.
Published: (2015-05-01)

Pathophysiology and Management of Fatigue in Neuromuscular Diseases
by: Francesca Torri, et al.
Published: (2023-03-01)

Cardiomyopathy secondary to Duchenne muscular dystrophy in children
by: Iulia Rodoman, et al.
Published: (2021-06-01)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Editorial: Lessons Learned from Translational Research in Neuromuscular Diseases: Impact on Study Design, Outcome Measures and Managing Expectation
by: Anna G. Mayhew, et al.
Published: (2022-07-01)

Research highlights of partial neuromuscular disorders
by: Cheng ZHANG
Published: (2014-05-01)

The endosomal escape vehicle platform enhances delivery of oligonucleotides in preclinical models of neuromuscular disorders
by: Xiang Li, et al.
Published: (2023-09-01)

New Therapeutics Options for Pediatric Neuromuscular Disorders
by: Marina Flotats-Bastardas, et al.
Published: (2020-11-01)

The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study
by: Aydan Kansu, et al.
Published: (2023-09-01)

Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia
by: Abdulaziz S. AlSaman, et al.
Published: (2022-09-01)

Genotype–Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry
by: Kenji Rowel Q. Lim, et al.
Published: (2020-11-01)

Lower extremity joint contracture according to ambulatory status in children with Duchenne muscular dystrophy
by: Young-Ah Choi, et al.
Published: (2018-08-01)

Duchenne muscular dystrophy: Genetic and clinical profile in the population of Rajasthan, India
by: Manisha Goyal, et al.
Published: (2021-01-01)

Research advance and application prospect of therapeutic strategies for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2018-07-01)

Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01)

Review the history of Duchenne muscular dystrophy and seize the cutting-edge research
by: Cheng ZHANG
Published: (2015-05-01)

Gene-based therapies for neuromuscular disorders
by: Edmar Zanoteli, et al.
Published: (2024-06-01)

Feasibility and effectiveness of a novel dynamic arm support in persons with spinal muscular atrophy and duchenne muscular dystrophy
by: Mariska M. H. P. Janssen, et al.
Published: (2021-05-01)

FRONTAL AND SAGITTAL PATTERNS OF NEUROMUSCULAR SPINAL DEFORMITIES BASED ON NOSOLOGICAL PROFILE
by: Egor U. Filatov, et al.
Published: (2022-11-01)

A Scoping Review of the Recent Clinical Practice Regarding the Evaluation of Bone Mineral Density in Children and Adolescents with Neuromuscular Diseases
by: Georgia Antoniou, et al.
Published: (2023-02-01)

Analysis of DMD translocations
by: Cockburn, D, et al.
Published: (1991)

Gene therapy for selected neuromuscular and trinucleotide repeat disorders – An insight to subsume South Asia for multicenter clinical trials
by: Nalaka Wijekoon, et al.
Published: (2023-06-01)

Muscular dystrophies: key elements for everyday diagnosis and management
by: Alberto Palladino, et al.
Published: (2013-12-01)

A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data
by: Zhihao Xie, et al.
Published: (2024-02-01)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
by: Martina Sandonà, et al.
Published: (2023-02-01)

Assessment of Weighted Gene Co-Expression Network Analysis to Explore Key Pathways and Novel Biomarkers in Muscular Dystrophy
by: Xu X, et al.
Published: (2021-04-01)

Comprehensive genetic characteristics of dystrophinopathies in China
by: Peipei Ma, et al.
Published: (2018-07-01)

Short-term treatment with Uncaria tomentosa aggravates the injury phenotype in mdx mice
by: David Feder, et al.
Published: (2024-03-01)

Estimated costs for Duchenne muscular dystrophy care in Brazil
by: Nayê Balzan Schneider, et al.
Published: (2023-06-01)